Stock market announcement archive

Lifecare – Successful completion of private placement

October 26, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the announcement published on 26 October 2022 by LifecareAS […]
Read more

Lifecare – Contemplated private placement

October 26, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Lifecare AS ("Lifecare" or the "Company") has retained Carnegie AS as bookrunnerand manager […]
Read more

Presentation on Nordic Life Science Congress and updated Investor Presentation – Lifecare Newsletter

October 7, 2022
Bergen, Norway 7 October 2022 Watch Lifecare's company presentation at the LSX Nordic Congress for LiceScience and Investor executives in Copenhagen, take a look at our updatedinvestor presentation and our new animation video explaining our technology. Read more in Lifecare's newsletter:https://lifecare.no/news/information-from-lifecare-october-2022/This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for […]
Read more

LIFE: Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations

September 27, 2022
Conducting clinical trials on humans is a significant step towards Lifecare'sgoal of contributing to helping people with diabetes to live a normal life. The purpose of the first study is to optimize signal reading from the company'sgroundbreaking sensor technology for continuous glucose monitoring for peoplewith diabetes. The glucose sensor for the clinical trials is produced […]
Read more

Lifecare signs Letter of Intent – Production location in Mainz

September 14, 2022
Bergen, Norway 14.9.22 Lifecare AS (Lifecare) has signed a Letter of Intent (LOI) with InnovationsparkMainz GmbH & Co KG (IVP). On this basis Lifecare and IVP will initiate anintensive joint development of a new Lifecare manufacturing location in Mainz(Germany), with an optimized infrastructure for sensor-production. In additionto production, Lifecare intends to integrate and co-locate the […]
Read more

Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity

August 25, 2022
Bergen, 25 August 2022. Today, Lifecare present strong financial results following the first half-yearwith operational activities in two German subsidiaries as part of the LifecareGroup. The external revenue in 1H 2022 reached a total of 8,7MNOK, representingan increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021(from 1,6MNOK). A steep increase […]
Read more

Lifecare innovations categorised by EU Innovation Radar as “Market Ready” and among top 14 % in terms of “Market Creation Potential” – Lifecare newsletter August 2022

August 8, 2022
Bergen, Norway 8 August 2022Independent experts from the European Commission's Innovation Radar havereviewed Lifecares technology in the EU funded project FORGETDIABETES. Thereview concludes that Lifecare's innovations are "Market Ready" and consideredamong the top 14% of innovations in scientific projects receiving financialgrants from the European Commission.Lifecare's involvement in the project FORGETDIABETES involves two keyinnovations: 1. Lifecare […]
Read more

Subscriptions by primary insiders and employees under Lifecare Employee Share Purchase Program – Registration of new share capital

July 26, 2022
Bergen, Norway 26.7.22Reference is made to Stock Exchange Announcement 15 July 2022 regardingsubscriptions under Lifecare Employee Share Purchase Program and the share issueresolved by Lifecare's Board of Directors. Employees in the Lifecare Group have been allocated in total 124 719 shares, ofwhich primary insiders Joacim Holter (Lifecare CEO) and Prof. Andreas Pfützner(Lifecare CSO) both have […]
Read more

Lifecare Employee Share Purchase Program – Subscriptions by Primary Insiders – Increase of share capital

July 15, 2022
Bergen, Norway 15.7.22Reference is made to Stock Exchange Announcement 23 May 2022 regarding theestablishment of Lifecare Group incentive program. All employees in the Lifecare Group have been invited to participate inLifecares Employee Share Purchase Program 2022 and individually subscribe for upto 20 000 shares with a 25% discount off the volume weighted average share price(VWAP) […]
Read more

LIFE: Lifecare Newsletter July

July 4, 2022
Bergen, Norway 4 June 2022 Lifecare achieved the two major milestones for 1H2022 in June, the clinicalstudy announced 23 June has started and Lifecare continue to strengthen theorganization. Read more in the Lifecare July newsletter:https://lifecare.no/news/information-from-lifecare-july-2022/ This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of […]
Read more